FindTrial
Sign In

Survey to Assess Potential Acceptance of COVID 19 Vaccine in Pregnant and Lactating Women

Potential Acceptance of COVID 19 Vaccine in Pregnant and Lactating Women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032615
Enrollment
300
Registered
2021-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant and Lactating Women

Exclusion criteria

Exclusion criteria: Women who are surrogates are not eligible for the study Women who are not willing to participate due to any reason

Design outcomes

Primary

MeasureTime frame
at the end of the survey we will be able to determine prevalence and acceptance of COVID 19 vaccine in pregnant and lactating populationTimepoint: 24 weeks—

Secondary

MeasureTime frame
Barriers faced by pregnant and lactating women to get vaccinatedTimepoint: 24 weeks—

Countries

India

Contacts

Public ContactMs Hafsa Shaikh

Manipal College of Pharmaceutical Sciences, MAHE

kanavworld@gmail.com7889271828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026